Literature DB >> 24902580

Long term outcome of multidrug-resistant TB patients in Fukujuji Hospital in Japan.

Takashi Yoshiyama1, Kozo Morimoto2, Masao Okumura2, Yuka Sasaki2, Hideo Ogata2, Yuji Shiraishi2, Shoji Kudou2.   

Abstract

OBJECTIVE: To present the long-term outcome of multidrug-resistant tuberculosis (MDR TB) patients.
METHODS: An observational study of 291 MDR TB cases that were diagnosed from 1990 to 2011 at the Fukujuji Hospital in Japan.
RESULTS: The frequency of relapse after cure was 3/168 (1.8%) during a mean follow-up of 4.4 years. Among 16 failure cases, eight patients were negative in later years. One case among the nine lost-to-follow-up patients with culture conversion returned 1.5 years later with positive culture.
CONCLUSIONS: Chronic-positive patients remain positive for years and require observation. Lost to follow-up cases may relapse.
© The Author 2014. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Japan; Multidrug-resistant tuberculosis; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24902580     DOI: 10.1093/trstmh/tru080

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan.

Authors:  Meng-Yu Chen; Yi-Chun Lo; Wan-Chin Chen; Kwei-Feng Wang; Pei-Chun Chan
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

2.  Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.

Authors:  J M Mangan; T E Tupasi; A M C G Garfin; V Lofranco; R Orillaza-Chi; R Basilio; L C Naval; G I Balane; E S Joson; D Burt; W-J Lew; M Mantala; S Pancho; J N Sarol; A Golubkov; E V Kurbatova
Journal:  Int J Tuberc Lung Dis       Date:  2016-09       Impact factor: 2.373

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.